Glaxis Capital Management’s Amgen AMGN Stock Holding History

Glaxis Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,500	Closed	-$1.09M	–	36
2024 Q2	$1.09M	Buy	3,500 +1,000	+40%	+$294K	1.89%	17
2024 Q1	$711K	Buy	+2,500	New	+$732K	1.32%	25
2016 Q1	–	Sell	-11,132	Closed	-$1.81M	–	5
2015 Q4	$1.81M	Buy	+11,132	New	+$1.75M	7.88%	6

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Glaxis Capital Management's AMGN Position: Q3 2024 in Review

Glaxis Capital Management sold out of Amgen (AMGN) in Q3 2024, closing a stake of 3,500 shares — an estimated $1.09M sold.

Glaxis Capital Management first reported a position in AMGN in Q4 2015 and held it in 3 quarters. The position peaked at $1.81M in Q4 2015. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

Glaxis Capital Management reported no remaining Amgen position as of Q3 2024 after selling out during the quarter.
Glaxis Capital Management sold 3,500 Amgen shares in Q3 2024, an estimated $1.09M.
Glaxis Capital Management first reported a position in Amgen in Q4 2015 and held it in 3 quarters.
Glaxis Capital Management's Amgen position peaked at $1.81M in Q4 2015.
2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Glaxis Capital Management's 13F filing for Q3 2024, filed 8 Nov 2024.